Eton Pharmaceuticals (ETON) Accumulated Expenses (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Accumulated Expenses of $9.4 million for Q4 2025, up 3.19% sequentially from $9.1 million in Q3 2025, and up 5.54% YoY from $8.9 million in Q4 2024.
Eton Pharmaceuticals (ETON) Accumulated Expenses (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Accumulated Expenses for 9 years, with the latest figure at $9.4 million in Q4 2025.
- Quarterly Accumulated Expenses rose 5.54% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (up 5.54% YoY) and the FY2025 annual result came in at $9.4 million, up 5.54% from the prior year.
- Accumulated Expenses grew to $9.4 million in Q4 2025 per ETON's latest filing, from $9.1 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $9.4 million in Q4 2025 and troughed at $22000.0 in Q2 2021.
- A 5-year average of $4.4 million and a median of $4.3 million in 2022 frame the typical range for Accumulated Expenses.
- The sharpest annual moves came in 2024 and 2025: Accumulated Expenses slumped 99.33% in 2024, then surged 18893.75% in 2025.
- Over 5 years, Accumulated Expenses stood at $1.4 million in 2021, then jumped by 168.08% to $3.7 million in 2022, then surged by 47.08% to $5.4 million in 2023, then jumped by 65.5% to $8.9 million in 2024, then climbed by 5.54% to $9.4 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $9.4 million, $9.1 million, and $7.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.65 Bn | 25.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.93 Mn |
| Dec 31, 2025 | 9.41 Mn |
| Sep 30, 2025 | 9.12 Mn |
| Jun 30, 2025 | 7.46 Mn |
| Mar 31, 2025 | 7.54 Mn |
| Dec 31, 2024 | 8.91 Mn |
| Sep 30, 2024 | 48,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 8.02 Mn |
| Dec 31, 2023 | 5.39 Mn |
| Sep 30, 2023 | 7.14 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 4.92 Mn |
| Dec 31, 2022 | 3.66 Mn |
| Sep 30, 2022 | 2.90 Mn |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | 1.35 Mn |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | 995,000.00 |
| Jun 30, 2021 | 22,000.00 |